From research results to innovation and competitiveness
Sweden has strong research and expertise in life science. The programme will help ensure that this strength is translated to a greater extent into innovation, growing companies and new investments.
Through cross-sectoral and international collaboration, the programme will create better conditions for developing groundbreaking solutions and help give Swedish industry a leading role in the life sciences of the future, such as advanced therapies, medical technology and biotechnology, and synthetic biology.

The initiatives will strengthen the ability to take research results and technological breakthroughs further through development, scaling up, utilisation and commercialisation. Collaboration, knowledge transfer, expertise and access to relevant infrastructure are important prerequisites for this.
– Sweden has strong research and innovation capacity in life science. Through the programme, we want to strengthen the ability to translate that strength into innovation, business and investments, thereby strengthening Sweden’s international competitiveness, says Karin Stenström, who is responsible for Vinnova’s Advanced Life Science programme.
The programme is a long-term effort. At present, the government assignment covers funding and planning up to 2028.

Karin Stenström, who is responsible for Vinnova’s Advanced Life Science programme.
CCRM Nordic strengthens capacity in advanced therapies
The government assignment consists of two parts: establishing the new Advanced Life Science programme and continuing to support the establishment of CCRM Nordic.
CCRM Nordic has a particular focus on advanced therapies and will help strengthen capacity for process development, scaling up, manufacturing and commercialisation. The initiative thus complements the programme’s focus on strengthened innovative capacity and competitiveness in life science.
Collaboration, expertise and infrastructure create conditions for innovation
To strengthen Sweden’s innovative capacity and competitiveness, long-term collaboration is needed between industry, academia, research institutes and other relevant actors.
Industry is to contribute through extensive co-financing in accordance with the government’s assignment.
Opening of the first the call for proposals on 1 October 2026
On 1 October, Vinnova opened the first the call for proposals under the Advanced Life Science programme. Companies, academia and other relevant actors can apply for funding to jointly develop innovative and sustainable technologies, products and processes.
Read the call text: Innovative solutions for the life science of the future
– The first the call for proposals is an important step in translating the programme’s ambitions into concrete innovation projects and strengthening Sweden’s position in the life science of the future, says Karin Stenström.
Read more about Vinnova’s life science initiatives